Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now later-stage tilt small index

Venous Stasis: later-stage trial registry

4 of 7 indexed Venous Stasis trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

7 US clinical trials · 4 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Venous Stasis: 7 US clinical trials tracked, 4 recruiting.

Venous Stasis is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is TR Therapeutics, running 2 of these trials.

Enrollment posture brief

Registry condition venous-stasis

OPEN 4 | RECR 57% | LATE 2 | EARLY 1 | RANK #2497 | SPON 2

Nearest open-share peer: Adverse Childhood Experiences (57% recruiting · 14 trials)

ACL Tear71.4%ACL57.1%Venous Stasis (this)57%Acute Myelogenous Leukemia42.9%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Venous Stasis

Venous Stasis lists 4 open slots (57% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Venous Stasis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Venous Stasis is recruiting above its size-band peers.

    4 of 7 indexed trials (57.1%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Venous Stasis research.

    TR Therapeutics accounts for 2 of 7 trials (28.6%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical Venous Stasis enrolment sits around 165 participants.

    Median target enrolment is 165 among the 7 trials that report a genuine target (sentinel values excluded). 2 of those (28.6%) plan for fewer than 100 participants.

  4. Venous Stasis research is mostly interventional.

    7 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 32

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 3 2

Named interventions

Most-linked intervention names on Venous Stasis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

GORE® VIAFORT Vascular Stent Device
2 trials
TR987 0.1% gel + Standard of Care Drug
2 trials
Standard of care Other
2 trials
Refence Therapy 2 Device
1 trials
Reference Therapy 1 Device
1 trials
OsciPulse system Device
1 trials
Stents Device
1 trials
BR-AC Other
1 trials

US sites by state

Facility locations filed on Venous Stasis trials. A trial with sites in several states counts in each.

Illinois 5 trials
California 5 trials
New York 4 trials
Florida 4 trials
North Carolina 3 trials
Michigan 3 trials
Ohio 2 trials
Missouri 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Venous Stasis page

7 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Venous Stasis condition card totals 7 registered trials; most-linked intervention GORE® VIAFORT Vascular Stent; top US site state Illinois. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.